BIA
WST icon

Bell Investment Advisors’s West Pharmaceutical WST Stock Holding History

Bell Investment Advisors’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$18.7K Buy
52
+2
+4% +$611 ﹤0.01% 490
2026
Q1 		$12.5K Sell
50
-2
-4% -$498 ﹤0.01% 603
2025
Q4 		$14.3K Sell
52
-2
-4% -$547 ﹤0.01% 566
2025
Q3 		$14.2K Buy
54
+2
+4% +$486 ﹤0.01% 518
2025
Q2 		$11.4K Sell
52
-25
-32% -$5.34K ﹤0.01% 625
2025
Q1 		$17.2K Buy
77
+3
+4% +$827 ﹤0.01% 430
2024
Q4 		$24.2K Sell
74
-2
-3% -$629 ﹤0.01% 341
2024
Q3 		$22.8K Sell
76
-11
-13% -$3.37K ﹤0.01% 366
2024
Q2 		$28.7K Hold
87
– – 0.01% 309
2024
Q1 		$34.4K Hold
87
– – 0.01% 266
2023
Q4 		$30.6K Sell
87
-1
-1% -$354 0.01% 264
2023
Q3 		$33K Sell
88
-4
-4% -$1.55K 0.01% 225
2023
Q2 		$35.2K Buy
92
+2
+2% +$714 0.01% 210
2023
Q1 		$31.2K Hold
90
– – 0.01% 224
2022
Q4 		$21.2K Buy
90
+31
+53% +$7.35K 0.01% 292
2022
Q3 		$15K Sell
59
-34
-37% -$10.4K ﹤0.01% 319
2022
Q2 		$28K Buy
+93
New +$30.3K 0.01% 214
2021
Q4 		$36K Buy
77
+18
+31% +$7.75K 0.01% 198
2021
Q3 		$25K Buy
+59
New +$24.9K 0.01% 247

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Bell Investment Advisors's WST Position: Q2 2026 in Review

Bell Investment Advisors increased its West Pharmaceutical (WST) stake by 4% in Q2 2026, buying an estimated $611 and bringing the position to 52 shares worth $18.7K. The position accounts for ﹤0.01% of the portfolio, ranked #490.

Bell Investment Advisors first reported a position in WST in Q3 2021 and has held it in 19 quarters since. The position peaked at $36K in Q4 2021. 834 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Bell Investment Advisors held 52 shares of West Pharmaceutical worth $18.7K as of Q2 2026.
  • Bell Investment Advisors bought 2 West Pharmaceutical shares in Q2 2026, an estimated $611.
  • West Pharmaceutical made up ﹤0.01% of Bell Investment Advisors's portfolio in Q2 2026, its #490 holding.
  • Bell Investment Advisors first reported a position in West Pharmaceutical in Q3 2021 and has held it in 19 quarters since.
  • Bell Investment Advisors's West Pharmaceutical position peaked at $36K in Q4 2021.
  • 834 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Bell Investment Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.